Nurse Practitioner Program year 2023 Reported 2021–2023 Source: CMS Open Payments, 2026 publication

Amy Hudson

Nurse Practitioner Asheville, NC Nurse Practitioner

NPI 1821344060 CMS profile 10476902

509 Biltmore Ave, Asheville, NC 28801

Open in the dashboard

General payments

$3,011

169 records reported · program years 2021–2023

Research payments

$0

Paid to them · None reported · program years 2021–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Amy Hudson of Asheville, NC is reported in the CMS Open Payments database as having received $3,011 across 169 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $373 21
2022 General $1,558 92
2021 General $1,080 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amy Hudson
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Amy Hudson were reported at $0. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Amy Hudson Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $1,080 $135 $40–$426 $132
2022 $1,558 $152 $48–$470 $149
2023 $373 $166 $54–$529 $160
2024 $0 $173 $55–$556 $164
2025 $0 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2023
  1. Lilly USA, LLC $326 19 payments
  2. Amgen Inc. $291 12 payments
  3. Sanofi-Aventis U.S. LLC $259 11 payments
  4. Boehringer Ingelheim Pharmaceuticals, Inc. $214 16 payments
  5. Novo Nordisk Inc $193 14 payments
  6. Salix Pharmaceuticals, a division of Bausch Health US, LLC $188 11 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $183 10 payments
  8. AbbVie, Inc. $175 13 payments
  9. Bayer HealthCare Pharmaceuticals Inc. $169 9 payments
  10. Janssen Pharmaceuticals, Inc $148 11 payments
  11. Other $866 43 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2023
  1. Food and Beverage $3,011 169 payments
Products named General payments · program years 2021–2023
  1. TRULICITY $303 17 payments
  2. Prolia $230 8 payments
  3. XIFAXAN $188 11 payments
  4. TRINTELLIX $183 10 payments
  5. Kerendia $169 9 payments
  6. Ozempic $168 12 payments
  7. RYBELSUS $168 12 payments
  8. JARDIANCE $165 9 payments
  9. NURTEC ODT $153 8 payments
  10. XARELTO $148 11 payments
  11. Other $2,292 143 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

241

Median for Nurse Practitioner: 389

Drug cost

$10,453

Median for Nurse Practitioner: $21,885

Branded share of claims

17.4%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 16 $9,344
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 26 $167
Amlodipine Besylate Generic 28 $167
Metoprolol Succinate Generic 27 $157
Cefadroxil Generic 20 $132
Spironolactone Generic 19 $100
Atorvastatin Calcium Generic 14 $86
Pantoprazole Sodium Generic 15 $81
Oxycodone Hcl Generic 14 $60
Furosemide Generic 18 $56

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$50,280

Medicare's payments for the services billed

Medicare patients

268

Average age 79

Services billed

673

147 women, 121 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Atrial fibrillation 43%
Heart failure 40%
Chronic kidney disease 38%
Depression 37%
COPD 35%
Ischemic heart disease 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

169 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record